News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Fuso Pharmaceutical Ind., Ltd. And HuBit Genomix To Co-develop Therapeutic And In-Vitro Diagnostic Drugs For Diabetes-Related Complications



10/19/2005 5:12:44 PM

Tokyo (JCNN) - Fuso Pharmaceutical Industries has announced that it has concluded a collaborative research agreement with HuBit genomix, a Tokyo-based biotech firm.

Read at JCN Newswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES